Skip to main content

Advertisement

SpringerLink
Log in

Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE/C6 ELISA and Immunoblot

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention (2004) Lyme Disease-United States 2001–2002. Morb Mortal Wkly Rep 53:365–369

    Google Scholar 

  2. Rosa PA, Tilly K, Stewart PE (2005) The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol 3:129–143

    Article  PubMed  CAS  Google Scholar 

  3. Padula SJ, Dias F, Sampieri A, Craven RB, Ryan RW (1994) Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J Clin Microbiol 32:1733–1738

    PubMed  CAS  Google Scholar 

  4. Sung SY, McDowell JV, Marconi RT (2001) Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes. J Bacteriol 183:5855–5861

    Article  PubMed  CAS  Google Scholar 

  5. Lawrenz MB, Hardham JM, Owens RT et al (1999) Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 37:3997–4004

    PubMed  CAS  Google Scholar 

  6. Philipp MT, Marques AR, Fawcett PT, Dally LG, Martin DS (2004) C6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis. J Clin Microbiol 41:4955–4960

    Article  Google Scholar 

  7. Hauser U, Lehnert G, Wilske B (1999) Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 37:2241–2247

    PubMed  CAS  Google Scholar 

  8. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP (2005) Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18:484–509

    Article  PubMed  CAS  Google Scholar 

  9. Centers for Disease Control and Prevention (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 44:590–591

    Google Scholar 

  10. Marangoni A, Sambri V, Accardo S et al (2006) A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin Vaccine Immunol 13:525–529

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Microbiology, Department of Laboratory Medicine, Malmö University Hospital, Lund University, 205 02, Malmö, Sweden

    K. Riesbeck & B. Hammas

Authors
  1. K. Riesbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Hammas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Riesbeck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riesbeck, K., Hammas, B. Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE/C6 ELISA and Immunoblot. Eur J Clin Microbiol Infect Dis 26, 517–519 (2007). https://doi.org/10.1007/s10096-007-0329-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-007-0329-x

Keywords

Search

Navigation